18-62360008-C-T

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_003839.4(TNFRSF11A):​c.575C>T​(p.Ala192Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.521 in 1,612,518 control chromosomes in the GnomAD database, including 221,917 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★). Synonymous variant affecting the same amino acid position (i.e. A192A) has been classified as Likely benign.

Frequency

Genomes: 𝑓 0.56 ( 24523 hom., cov: 32)
Exomes 𝑓: 0.52 ( 197394 hom. )

Consequence

TNFRSF11A
NM_003839.4 missense

Scores

18

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: 0.391

Publications

111 publications found
Variant links:
Genes affected
TNFRSF11A (HGNC:11908): (TNF receptor superfamily member 11a) The protein encoded by this gene is a member of the TNF-receptor superfamily. This receptors can interact with various TRAF family proteins, through which this receptor induces the activation of NF-kappa B and MAPK8/JNK. This receptor and its ligand are important regulators of the interaction between T cells and dendritic cells. This receptor is also an essential mediator for osteoclast and lymph node development. Mutations at this locus have been associated with familial expansile osteolysis, autosomal recessive osteopetrosis, and Paget disease of bone. Alternatively spliced transcript variants have been described for this locus. [provided by RefSeq, Aug 2012]
TNFRSF11A Gene-Disease associations (from GenCC):
  • Paget disease of bone 2, early-onset
    Inheritance: AD Classification: STRONG, MODERATE Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae)
  • autosomal recessive osteopetrosis 7
    Inheritance: AR Classification: STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Genomics England PanelApp, Ambry Genetics, Orphanet
  • familial expansile osteolysis
    Inheritance: AD Classification: MODERATE, SUPPORTIVE Submitted by: Orphanet, Ambry Genetics
  • dysosteosclerosis
    Inheritance: AR Classification: SUPPORTIVE, LIMITED Submitted by: Ambry Genetics, Orphanet
  • osteosarcoma
    Inheritance: AD Classification: LIMITED Submitted by: Genomics England PanelApp

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=5.930566E-6).
BP6
Variant 18-62360008-C-T is Benign according to our data. Variant chr18-62360008-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 259182.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.672 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
TNFRSF11ANM_003839.4 linkc.575C>T p.Ala192Val missense_variant Exon 6 of 10 ENST00000586569.3 NP_003830.1 Q9Y6Q6-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
TNFRSF11AENST00000586569.3 linkc.575C>T p.Ala192Val missense_variant Exon 6 of 10 1 NM_003839.4 ENSP00000465500.1 Q9Y6Q6-1
TNFRSF11AENST00000269485.11 linkc.575C>T p.Ala192Val missense_variant Exon 6 of 7 1 ENSP00000269485.7 Q9Y6Q6-2
TNFRSF11AENST00000587697.1 linkn.493C>T non_coding_transcript_exon_variant Exon 2 of 2 3

Frequencies

GnomAD3 genomes
AF:
0.563
AC:
85554
AN:
151866
Hom.:
24478
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.639
Gnomad AMI
AF:
0.491
Gnomad AMR
AF:
0.625
Gnomad ASJ
AF:
0.545
Gnomad EAS
AF:
0.690
Gnomad SAS
AF:
0.411
Gnomad FIN
AF:
0.529
Gnomad MID
AF:
0.554
Gnomad NFE
AF:
0.511
Gnomad OTH
AF:
0.600
GnomAD2 exomes
AF:
0.545
AC:
136972
AN:
251466
AF XY:
0.531
show subpopulations
Gnomad AFR exome
AF:
0.646
Gnomad AMR exome
AF:
0.664
Gnomad ASJ exome
AF:
0.551
Gnomad EAS exome
AF:
0.699
Gnomad FIN exome
AF:
0.532
Gnomad NFE exome
AF:
0.510
Gnomad OTH exome
AF:
0.543
GnomAD4 exome
AF:
0.516
AC:
753844
AN:
1460534
Hom.:
197394
Cov.:
46
AF XY:
0.512
AC XY:
371717
AN XY:
726618
show subpopulations
African (AFR)
AF:
0.643
AC:
21515
AN:
33448
American (AMR)
AF:
0.664
AC:
29671
AN:
44716
Ashkenazi Jewish (ASJ)
AF:
0.545
AC:
14224
AN:
26120
East Asian (EAS)
AF:
0.687
AC:
27281
AN:
39686
South Asian (SAS)
AF:
0.399
AC:
34427
AN:
86234
European-Finnish (FIN)
AF:
0.532
AC:
28380
AN:
53382
Middle Eastern (MID)
AF:
0.515
AC:
2968
AN:
5766
European-Non Finnish (NFE)
AF:
0.507
AC:
563500
AN:
1110838
Other (OTH)
AF:
0.528
AC:
31878
AN:
60344
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.460
Heterozygous variant carriers
0
19064
38129
57193
76258
95322
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
16434
32868
49302
65736
82170
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.564
AC:
85661
AN:
151984
Hom.:
24523
Cov.:
32
AF XY:
0.565
AC XY:
41959
AN XY:
74308
show subpopulations
African (AFR)
AF:
0.640
AC:
26524
AN:
41468
American (AMR)
AF:
0.626
AC:
9547
AN:
15254
Ashkenazi Jewish (ASJ)
AF:
0.545
AC:
1892
AN:
3472
East Asian (EAS)
AF:
0.691
AC:
3577
AN:
5178
South Asian (SAS)
AF:
0.412
AC:
1983
AN:
4818
European-Finnish (FIN)
AF:
0.529
AC:
5576
AN:
10544
Middle Eastern (MID)
AF:
0.561
AC:
165
AN:
294
European-Non Finnish (NFE)
AF:
0.511
AC:
34701
AN:
67950
Other (OTH)
AF:
0.596
AC:
1249
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.504
Heterozygous variant carriers
0
1904
3807
5711
7614
9518
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
718
1436
2154
2872
3590
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.529
Hom.:
107962
Bravo
AF:
0.580
TwinsUK
AF:
0.505
AC:
1872
ALSPAC
AF:
0.528
AC:
2035
ESP6500AA
AF:
0.632
AC:
2786
ESP6500EA
AF:
0.511
AC:
4397
ExAC
AF:
0.537
AC:
65161
Asia WGS
AF:
0.569
AC:
1979
AN:
3478
EpiCase
AF:
0.521
EpiControl
AF:
0.524

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Nov 12, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is associated with the following publications: (PMID: 20564239, 21987421) -

not specified Benign:2
-
PreventionGenetics, part of Exact Sciences
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Increased bone mineral density Benign:1
Jun 17, 2022
Genome Diagnostics Laboratory, The Hospital for Sick Children
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Bone Paget disease Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Osteopetrosis Benign:1
Jun 14, 2016
Illumina Laboratory Services, Illumina
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.056
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.61
CADD
Benign
14
DANN
Benign
0.20
DEOGEN2
Benign
0.14
.;.;.;.;T
Eigen
Benign
-0.75
Eigen_PC
Benign
-0.56
FATHMM_MKL
Benign
0.032
N
LIST_S2
Benign
0.26
T;T;T;T;T
MetaRNN
Benign
0.0000059
T;T;T;T;T
MetaSVM
Benign
-0.93
T
MutationAssessor
Benign
-0.81
.;N;N;N;N
PhyloP100
0.39
PrimateAI
Benign
0.37
T
PROVEAN
Benign
1.4
.;N;.;.;.
REVEL
Benign
0.047
Sift
Benign
1.0
.;T;.;.;.
Sift4G
Benign
1.0
.;T;T;T;T
Polyphen
0.012
.;.;.;.;B
Vest4
0.083, 0.067, 0.049
MPC
1.1
ClinPred
0.0027
T
GERP RS
2.6
Varity_R
0.024
gMVP
0.75
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1805034; hg19: chr18-60027241; COSMIC: COSV54023702; API